{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:16:01Z","timestamp":1792602961663,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T00:00:00Z","timestamp":1379462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1245\/s10434-013-3260-7","type":"journal-article","created":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T11:56:05Z","timestamp":1379418965000},"page":"361-367","source":"Crossref","is-referenced-by-count":143,"title":["Androgen Receptor-Positive Triple Negative Breast Cancer: A Unique Breast Cancer Subtype"],"prefix":"10.1245","volume":"21","author":[{"given":"Lee J.","family":"McGhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl A.","family":"Protheroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amylou C.","family":"Dueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Nunez-Nateras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik P.","family":"Castle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Wasif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Goetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Hawse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis J.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather E.","family":"Cunliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Pockaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,18]]},"reference":[{"key":"3260_CR1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000158055","volume":"3","author":"K Tiefenbacher","year":"2008","unstructured":"Tiefenbacher K, Daxenbichler G. The role of androgens in normal and malignant breast tissue. Breast Care (Basel). 2008;3:325\u201331.","journal-title":"Breast Care (Basel)."},{"issue":"Pt 1","key":"3260_CR2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-130-4_Part_1-199902160-00004","volume":"130","author":"JA Cauley","year":"1999","unstructured":"Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1999;130(Pt 1):270\u20137.","journal-title":"Ann Intern Med."},{"key":"3260_CR3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.5732\/cjc.009.10673","volume":"29","author":"X Luo","year":"2010","unstructured":"Luo X, Shi YX, Li ZM, Jiang WQ. Expression and clinical significance of androgen receptor in triple negative breast cancer. Chin J Cancer. 2010;29:585\u201390.","journal-title":"Chin J Cancer."},{"key":"3260_CR4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/PPO.0b013e3181ce4ae1","volume":"16","author":"A Gucalp","year":"2010","unstructured":"Gucalp A, Traina TA. Triple-negative breast cancer: role of the androgen receptor. Cancer J. 2010;16:62\u20135.","journal-title":"Cancer J."},{"key":"3260_CR5","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938\u201348.","journal-title":"N Engl J Med."},{"key":"3260_CR6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/modpathol.2009.159","volume":"23","author":"LA Niemeier","year":"2010","unstructured":"Niemeier LA, Dabbs DJ, Beriwal S, Striebel JM, Bhargava R. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation. Mod Pathol. 2010;23:205\u201312.","journal-title":"Mod Pathol."},{"issue":"1","key":"3260_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.22381","volume":"109","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer. 2007 109(1):25\u201332.","journal-title":"Cancer."},{"key":"3260_CR8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12032-011-9832-0","volume":"29","author":"J He","year":"2012","unstructured":"He J, Peng R, Yuan Z, et al. Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray. Med Oncol. 2012;29:406\u201310.","journal-title":"Med Oncol."},{"key":"3260_CR9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/annonc\/mdp510","volume":"21","author":"S Park","year":"2010","unstructured":"Park S, Koo J, Park HS, et al. Expression of androgen receptors in primary breast cancer. Ann Oncol. 2010;21:488\u201392.","journal-title":"Ann Oncol."},{"key":"3260_CR10","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1158\/1078-0432.CCR-10-2021","volume":"17","author":"R Hu","year":"2011","unstructured":"Hu R, Dawood S, Holmes MD, et al. Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res. 2011;17:1867\u201374.","journal-title":"Clin Cancer Res."},{"key":"3260_CR11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10147-008-0770-6","volume":"13","author":"Y Ogawa","year":"2008","unstructured":"Ogawa Y, Hai E, Matsumoto K, et al. Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers. Int J Clin Oncol. 2008;13:431\u20135.","journal-title":"Int J Clin Oncol."},{"key":"3260_CR12","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121:2750\u201367.","journal-title":"J Clin Invest."},{"key":"3260_CR13","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0015-0282(02)02985-0","volume":"77","author":"HG Burger","year":"2002","unstructured":"Burger HG. Androgen production in women. Fertil Steril. 2002;77:S3\u20135.","journal-title":"Fertil Steril."},{"key":"3260_CR14","first-page":"529","volume":"126","author":"U Veronesi","year":"1968","unstructured":"Veronesi U, Pizzocaro G. Breast cancer in women subsequent to cystic disease of the breast. Surg Gynecol Obstet. 1968;126:529\u201332.","journal-title":"Surg Gynecol Obstet."},{"issue":"Suppl 1","key":"3260_CR15","first-page":"111","volume":"106","author":"YC Wong","year":"2001","unstructured":"Wong YC, Xie B. The role of androgens in mammary carcinogenesis. Ital J Anat Embryol. 2001;106(Suppl 1):111\u201325.","journal-title":"Ital J Anat Embryol."},{"key":"3260_CR16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0960-0760(95)00228-6","volume":"56\u20136","author":"R Hackenberg","year":"1996","unstructured":"Hackenberg R, Schulz KD. Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids. Steroid Biochem Mol Biol. 1996;56\u20136:113\u20137.","journal-title":"Steroid Biochem Mol Biol."},{"key":"3260_CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ijc.24709","volume":"126","author":"KN Danforth","year":"2010","unstructured":"Danforth KN, Eliassen AH, Tworoger SS, et al. The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women. Int J Cancer. 2010;126:199\u2013207.","journal-title":"Int J Cancer."},{"key":"3260_CR18","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1158\/1078-0432.CCR-08-1208","volume":"14","author":"BP Schneider","year":"2008","unstructured":"Schneider BP, Winer EP, Foulkes WD, Garber J, Perou CM. Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res. 2008;14:8010\u201318.","journal-title":"Clin Cancer Res."},{"key":"3260_CR19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2559.2007.02889.x","volume":"52","author":"JS Reis-Filho","year":"2008","unstructured":"Reis-Filho JS, Tutt ANJ. Triple negative tumours: a critical review. Histopathology. 2008;52:108\u201318.","journal-title":"Histopathology."},{"key":"3260_CR20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/GCO.0b013e3282f40de9","volume":"20","author":"SP Kanga","year":"2008","unstructured":"Kanga SP, Martelb M, Harris LN. Triple negative breast cancer: current understanding of biology. Curr Opin Obstet Gynecol. 2008;20:40\u20136.","journal-title":"Curr Opin Obstet Gynecol."},{"key":"3260_CR21","first-page":"29","volume":"4","author":"F Podoa","year":"2010","unstructured":"Podoa F, Buydensb LMC, Deganic H, et al. Triple-negative breast cancer: present challenges and new perspectives. Mol Oncol. 2010;4:2099\u201329.","journal-title":"Mol Oncol."},{"key":"3260_CR22","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/1097-0142(19841201)54:11<2436::AID-CNCR2820541121>3.0.CO;2-H","volume":"54","author":"RM Bryan","year":"1984","unstructured":"Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ. Androgen receptors in breast cancer. Cancer. 1984;54:2436\u201340.","journal-title":"Cancer."},{"key":"3260_CR23","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1158\/1078-0432.CCR-08-1763","volume":"15","author":"AM Gonzalez-Angulo","year":"2009","unstructured":"Gonzalez-Angulo AM, Stemke-Hale K, Palla SL, et al. Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer. Clin Cancer Res. 2009;15:2472\u20138.","journal-title":"Clin Cancer Res."},{"key":"3260_CR24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1309\/PEF8-GL6F-YWMC-AG56","volume":"117","author":"RL Parker","year":"2002","unstructured":"Parker RL, Huntsman DG, Lesack DW, Cupples JB, Grant DR, Akbari M, Gilks CB. Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. Am J Clin Pathol. 2002;117:723\u20138.","journal-title":"Am J Clin Pathol."},{"key":"3260_CR25","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/annonc\/mdq678","volume":"22","author":"S Park","year":"2011","unstructured":"Park S, Koo JS, Kim MS, et al. Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. Ann Oncol. 2011;22:1755\u201362.","journal-title":"Ann Oncol."},{"issue":"Suppl. 3","key":"3260_CR26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1245\/s10434-010-1260-4","volume":"17","author":"JA Billar","year":"2010","unstructured":"Billar JA, Dueck AC, Stucky CH, et al. Triple-negative breast cancers: unique clinical presentations and outcomes. Ann Surg Oncol. 2010;17(Suppl. 3):384\u201390.","journal-title":"Ann Surg Oncol."},{"key":"3260_CR27","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/modpathol.2011.54","volume":"24","author":"LC Collins","year":"2011","unstructured":"Collins LC, Cole KS, Marotti JD, et al. Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses\u2019 Health Study. Mod Pathol. 2011;24:924\u201331.","journal-title":"Mod Pathol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-3260-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-013-3260-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-3260-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T07:23:07Z","timestamp":1559632987000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-013-3260-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,18]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["3260"],"URL":"https:\/\/doi.org\/10.1245\/s10434-013-3260-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,18]]}}}